Probe panel seeks info from Sasikala, Apollo Hospital about Jaya's demise
Justice A Arumughaswamy, who heads the one-man commission, directed Sasikala to submit her response within 15 days22-12-2017
22-12-2017
Sub: Intimation Of Record Date And Interest Payment Date On Non Convertible Debentures (Ncds) Ref : Our Letter Dated 25Th November 2017
With reference to the captioned subject and in compliance with the Regulation 50 and 60 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that in terms of Information Memorandum, 21st December 2017 has been fixed as the record date for the payment of interest and full redemption on exercising call option by the Company, on the following series of debentures....04-12-2017
Apollo Hospitals eyes better margins next year
Apollo Hospitals' earnings were stable during the September quarter but it faced an incremental cost of Rs 35 crore02-12-2017
Updates
Dear Sir Sub : Notice to Debentureholders - Intimation of exercise of call option by the Company on 500 - 10.30% Secured Redeemable Non Convertible Debentures of Rs. 10,00,000/- each. Pursuant to Regulation 51 read with Part B of Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Notice to Debentureholders with regard to exercise...25-11-2017
Apollo Hospitals to take pharmacy store count to 3,000 in next 6 months
In the first half of the financial year, Apollo Hospitals has added 191 stores and closed five stores, for a net addition of 186 stores19-11-2017
Updates
Dear Sir, Sub: Certificate under Regulation 52(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Further to our letter dated 13th November 2017, please find enclosed a certificate received from Axis Trustee Services Limited, Debenture Trustee pursuant to Regulation 52(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015....18-11-2017
Apollo Hospitals says returns on cath labs halve due to stent price cut
Apollo Hospitals's returns on investment in cath labs comes down to 8% from 15-16% due to stent price cut, says CFO Krishnan Akhileswaran16-11-2017
Analyst / Investor Meet - Intimation
Further to our letter dated 18th October 2017, the Board of Directors at its meeting held on 13th November 2017 have approved the unaudited financial results of the Company for the quarter and half year ended 30th September 2017. Schedule of Conference Call Pursuant to Regulation 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a conference call for the analysts/investors...13-11-2017
Financial Results For The Quarter And Half Year Ended 30Th September 2017
Further to our letter dated 18th October 2017, the Board of Directors at its meeting held on 13th November 2017 have approved the unaudited financial results of the Company for the quarter and half year ended 30th September 2017. As required by the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, (LODR) we enclose/furnish the following particulars....13-11-2017